Labshake search
Citations for Stemcell Technologies :
251 - 300 of 1338 citations for Carboxypeptidase Y from Baker's Yeast since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2024Quote: ... the cells were plated in 6-well plates using mTeSR media supplemented with 10 µM Y-27632 (Stem Cell Technologies, catalog no. 72304) for 48 hours ...
-
bioRxiv - Neuroscience 2024Quote: Frozen DIV 4 stock of NGN2 iPSC-derived cortical neurons (Brigham & Women’s Hospital Neuro iHub) were gently thawed and resuspended in NB-B27 media with RHO/ROCK pathway inhibitor (RI, 10 μM, Stemcell Technologies, Y-27632). A small volume (10 μL ...
-
bioRxiv - Cell Biology 2024Quote: ... and then re-seeded in supplemented mTeSR1 medium with 1% P/S and a 10 μM concentration of the ROCK inhibitor Y-27632 (STEMCELL Technologies, Cat. # 72308). A comprehensive protocol is available at https://www.allencell.org/.
-
bioRxiv - Cell Biology 2024Quote: ... and then re-seeded in supplemented mTeSR1 medium with 1% penicillin–streptomycin and a 10 μM concentration of the ROCK inhibitor Y-27632 (Stem Cell Technologies, 72308). Further details for cell culture reagents and consumables can be found in the Resource Table and standard protocols can be found at www.allencell.org.
-
bioRxiv - Cell Biology 2024Quote: ... NGN2 and puromycin resistance expression was induced as follows: Seven million cells were passaged into pre-differentiation media containing Rock inhibitor (Y-27632, Dihydrochloride, Stem Cell Technologies 72304) and doxycycline (Sigma D3447 ...
-
bioRxiv - Neuroscience 2021Quote: ... and plated at 3 × 106 cells/well to allow the embryoid body (EB) formation in Neural Induction Media (NIM) + 10 μM Y-27632 (Stem Cell Technologies, Cat.No. 72308). They were allowed to attach for at least overnight ...
-
bioRxiv - Bioengineering 2023Quote: The hPSCs were cultured in NuwacellTM ncTarget hPSC Medium (Nuwacell Biotechnologies, RP01020, Hefei, China) with 10 μM Y-27632 (STEMCELL Technologies, 72304, BC, USA). The hNSCs were derived from hiPSCs which followed standard neurobiology protocols (Thermo Fisher Scientific) ...
-
bioRxiv - Developmental Biology 2022Quote: ... replated at a density of 1.58 × 105 cells/cm2 in Vitronectin XF-coated 24 well plate into cardiomyocyte media (RPMI, 2% B27 supplement plus insulin [Life Technologies Australia, Cat.#17504001], 10% FBS, and 10 µM Y-27362 ROCK inhibitor [Stem Cell Technologies, Cat.#72308]) and cultured overnight ...
-
bioRxiv - Developmental Biology 2021Quote: ... Medium was changed daily until cells were passaged at 80-90% confluency (medium supplemented with Y-27632 [cat. num. 72304; STEMCELL Technologies, Vancouver, Canada] for 24 hours) or induced into mesodermal differentiation at 30-40% confluency.
-
bioRxiv - Immunology 2021Quote: Peripheral blood mononuclear cells from healthy donors were purified from buffy coats purchased from Research Blood Components or leukopaks purchased from Stem Cell Technologies using Ficoll-Paque PLUS (GE Healthcare ...
-
bioRxiv - Cancer Biology 2024Quote: Leukopak from healthy donors was purchased from StemCell Technologies. T cells were separated by negative selection using EasySep™ Human T Cell Isolation Kit (StemCell ...
-
bioRxiv - Cell Biology 2024Quote: Leukopaks from anonymized donors were acquired from StemCell Technologies with approved IRBs ...
-
bioRxiv - Cancer Biology 2024Quote: Leukopaks from healthy donors were purchased from StemCell Technologies. Primary human T cells were purified by negative selection using the RosetteSep Human T cell Enrichment kit (StemCell Technologies ...
-
bioRxiv - Immunology 2021Quote: Peripheral blood mononuclear cells from healthy donors were purified from leukopaks purchased from Stem Cell Technologies using Ficoll-Paque PLUS (GE Healthcare ...
-
bioRxiv - Immunology 2020Quote: ... Control T cells were isolated from from leukapheresis products from healthy donors (STEMCELL Technologies, Vancouver, BC, Canada). This study was approved by the Research Ethics Board of the BC Cancer Agency/University of British Columbia (certificates H16-00291-A021 ...
-
bioRxiv - Cancer Biology 2024Quote: ... CD34+ cells from healthy donors were purchased from STEMCELL Technologies. Cryopreserved AML MNCs were resuspended in IMDM medium supplemented with 15% BIT (bovine serum albumin ...
-
bioRxiv - Immunology 2024Quote: ... Peripheral blood mononuclear cells (PBMCs) were isolated from leukapheresis samples from HIV negative donors obtained from Stemcell technologies. Naïve CD4+ T cells were magnetically isolated from thawed PBMCs using the EasySep™ Human Naïve CD4+ T Cell Isolation Kit (Stemcell ...
-
bioRxiv - Immunology 2023Quote: ... Frozen PBMC vials from healthy donors were purchased from STEMCELL Technologies. Beth Israel Deaconess Medical Center institutional review board approved this study ...
-
bioRxiv - Immunology 2024Quote: Leukopaks from healthy donors were obtained from StemCell Technologies (Vancouver, Canada). All samples were obtained with informed consent and ethical approval (The University of British Columbia Clinical Research Ethics Board number H15-02826) ...
-
bioRxiv - Immunology 2024Quote: ... Peripheral blood mononuclear cells (PBMCs) from de-identified healthy donors were purified from leukapheresis products purchased from Stem Cell Technologies using EasySep Direct Human PBMC Isolation Kits (Stem Cell Technologies) ...
-
bioRxiv - Bioengineering 2021Quote: Leukapheresis products from anonymous healthy human donors were purchased from STEMCELL Technologies, Inc ...
-
bioRxiv - Immunology 2023Quote: Leukapheresis product (leukopaks) from healthy human donors were obtained from Stemcell Technologies shipped on wet ice ...
-
bioRxiv - Immunology 2024Quote: ... Leukapheresis samples from deidentified HIV negative individuals were obtained from Stemcell Technologies. Ethical approval to conduct this study was obtained from George Washington University and the Weill Cornell Medicine Institutional Review Boards (Weill Cornel Medicine #1805019252 and George Washington University FWA#00005945) ...
-
bioRxiv - Bioengineering 2024Quote: ... obtained from Stemcell Technologies. The culture medium was supplemented with 50 ng mL-1 mSCF (PeproTech ...
-
bioRxiv - Microbiology 2023Quote: Human blood products from healthy donors were purchased from StemCell Technologies (Vancouver, Canada). Peripheral blood mononuclear cells (PBMCs ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs from healthy donors were isolated from leukocyte cones using Lymphoprep (Stemcell Technologies) gradient ...
-
bioRxiv - Cell Biology 2024Quote: Leukopaks from deidentified healthy donors with approved IRBs were purchased from StemCell Technologies. Primary human T cells were isolated with the EasySep Human T Cell Isolation Kit (StemCell Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... from anonymous healthy human donor blood collected by leukopheresis and purchased from STEMCELL technologies. T cells were cryopreserved in CryoStor10 (STEMCELL technologies) ...
-
bioRxiv - Immunology 2020Quote: ... PBMCs from the US were collected between 2016 - 2018 and purchased from Stemcell Technologies, Canada ...
-
bioRxiv - Bioengineering 2024Quote: ... human T cells were obtained from fresh Leukopaks purchased from STEMCELL Technologies (Seattle, WA). T cell isolation was performed on the CliniMACS system using anti-CD4 and CD8 magnetic beads (Miltenyi Biotec ...
-
bioRxiv - Cancer Biology 2022Quote: Primary T cells were isolated from LeukoPaks obtained from Stem Cell Technologies (200-0092). CD8 and CD4 cells were isolated separately using their EasySep™ Human CD8+/CD4+ T Cell Isolation Kit as per manufacturer’s instructions ...
-
bioRxiv - Genomics 2023Quote: ... or directly from vials containing isolated CD8+ T cells from individual donors (StemCell Technologies). For all technology development experiments ...
-
bioRxiv - Molecular Biology 2020Quote: ... was purchased from Stemcell technologies.
-
bioRxiv - Cancer Biology 2024Quote: ... Dispase was from Stemcell Technologies; Advanced-DMEM/F-12 was from ThermoFisher ...
-
bioRxiv - Cancer Biology 2024Quote: Human whole leukocytes from anonymous healthy donors were isolated from apheresis cones from ARUP using RBC sedimentation with HetaSep (STEMCELL Technologies, Vancouver, British Columbia). Freshly isolated whole leukocytes were used fresh for in vitro culture.
-
bioRxiv - Immunology 2020Quote: Purified CD34+ bone marrow cells from healthy individuals were either purchased directly from StemCell Technologies or isolated from fresh human bone marrow ...
-
bioRxiv - Immunology 2021Quote: Human peripheral blood from de-identified healthy donors was purchased from STEMCELL Technologies (Vancouver, Canada), which collects and distributes de-identified human blood products with consent forms ...
-
bioRxiv - Immunology 2023Quote: ... cells were collected from the supernatant and detached from the plate using ACCUTASE (STEMCELL Technologies) for assessment by flow cytometry.
-
bioRxiv - Molecular Biology 2024Quote: PBMCs were isolated from heparin blood using the SepMateTM PBMC isolation tubes from STEMCELL Technologies Inc ...
-
bioRxiv - Neuroscience 2024Quote: Neural progenitor cells (NPCs) derived from XCL-1 iPSCs were obtained from Stem Cell Technologies. NPCs were cultured on matrigel-coated plates (Corning ...
-
bioRxiv - Bioengineering 2021Quote: ... The B cells were isolated from fresh blood samples using negative selection kits from Stemcell Technologies (EasySep Direct Human B Cell Isolation Kit) ...
-
bioRxiv - Immunology 2022Quote: Frozen human bone marrow mononuclear cells (BMMC) from three healthy donors were purchased from STEMCELL Technologies and stored in liquid nitrogen until use ...
-
bioRxiv - Immunology 2024Quote: Human peripheral blood leukopaks from de-identified healthy donors were purchased from STEMCELL Technologies (Vancouver, Canada). CD4+ T cells and CD8+ T cells were enriched using the EasySep Human CD4+ T Cell Isolation Kit and EasySep Human CD8+ T Cell Isolation Kit (STEMCELL Technologies) ...
-
bioRxiv - Cell Biology 2024Quote: Human primary CD34+ HSPCs from G-CSF-mobilized healthy adult donors were obtained from StemCell Technologies. CD34+ HSPCs were expanded ...
-
bioRxiv - Genomics 2021Quote: ... PBMCs were sourced from Stemcell Technologies and prepared for sequencing using the 10X Genomics Chromium Single Cell 3’ Gene Expression Solution ...
-
bioRxiv - Molecular Biology 2021Quote: ... All kits are from STEMCELL Technologies, and differentiation was induced following the manufacturer’s protocol.
-
bioRxiv - Cell Biology 2021Quote: ... All supplements were from Stemcell Technologies unless otherwise specified ...
-
bioRxiv - Immunology 2021Quote: ... and protocols from Stem Cell Technologies. MAIT cells were sorted using a FACSAria III (BD Biosciences).
-
bioRxiv - Immunology 2020Quote: ... hPBMCs were purchased from STEMCELL Technologies.
-
bioRxiv - Cancer Biology 2023Quote: ... isolated from PBMCs (StemCell Technologies, 70025) using EasySepTM Human CD4+ T Cell Isolation Kit (StemCell Technologies ...